Suppr超能文献

血清前列腺特异性抗原(PSA)、游离前列腺特异性抗原(fPSA)和癌胚抗原(CEA)水平与前列腺癌预后及临床病理特征的相关性

Association of Serum PSA, fPSA, and CEA Levels with Prognosis and Clinicopathological Characteristics in Prostate Cancer.

作者信息

Ahamed Yeasin, Wu Lichao, Baral Shantanu, Al-Raiyan Ashab Uddin, Sun Weigui

机构信息

Department of Urology Surgery, The Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu, 225001, People's Republic of China.

Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, 225001, People's Republic of China.

出版信息

Cancer Manag Res. 2025 Aug 6;17:1577-1585. doi: 10.2147/CMAR.S514439. eCollection 2025.

Abstract

OBJECTIVE

To investigate the expression and influencing factors of serum prostate specific antigen (PSA), free prostate specific antigen (fPSA) and carcinoembryonic antigen (CEA) in patients with prostate cancer.

METHODS

Retrospective methods were used to select 120 patients with prostate cancer admitted to our hospital from January 2021 to December 2023 as prostate cancer group and 100 patients with benign hyperplasia of prostate as benign hyperplasia group. During the same period, 100 healthy subjects in physical examination center were selected as the healthy control group. Serum PSA, fPSA and CEA levels of the three groups of subjects were detected, and their differences in patients with different clinicopathological characteristics were compared. Multivariate logistic regression was used to analyze their independent risk factors.

RESULTS

The serum levels of PSA, fPSA and CEA in prostate cancer group were significantly higher than those in benign hyperplasia group, and the levels of PSA, fPSA and CEA in benign hyperplasia group were significantly higher than those in healthy control group, the difference was statistically significant (<0.05). Serum PSA, fPSA and CEA levels were significantly higher in patients aged ≥60 years old, Gleason score ≥7, TNM stage III+IV, high differentiated, with lymph node metastasis and bone metastasis than in patients aged < 60 years old, Gleason score < 7, TNM stage I+II, low differentiated, without lymph node metastasis or bone metastasis, the difference was statistically significant (<0.05). PSA≥10.05 μg/mL, fPSA≥1.50 μg/mL, CEA≥20 ng/mL were independent risk factors for poor prognosis of prostate cancer (<0.05).

CONCLUSION

Serum PSA, fPSA and CEA are significantly elevated in patients with prostate cancer, which are independent risk factors for poor prognosis and can be used as important indicators for clinicopathological evaluation and prognosis prediction.

摘要

目的

探讨前列腺癌患者血清前列腺特异性抗原(PSA)、游离前列腺特异性抗原(fPSA)及癌胚抗原(CEA)的表达情况及其影响因素。

方法

采用回顾性方法,选取2021年1月至2023年12月我院收治的120例前列腺癌患者作为前列腺癌组,100例前列腺良性增生患者作为良性增生组。同期选取体检中心100例健康体检者作为健康对照组。检测三组受试者血清PSA、fPSA及CEA水平,并比较不同临床病理特征患者之间的差异。采用多因素logistic回归分析其独立危险因素。

结果

前列腺癌组血清PSA、fPSA及CEA水平显著高于良性增生组,良性增生组血清PSA、fPSA及CEA水平显著高于健康对照组,差异有统计学意义(<0.05)。年龄≥60岁、Gleason评分≥7、TNM分期III+IV、高分化、有淋巴结转移及骨转移的患者血清PSA、fPSA及CEA水平显著高于年龄<60岁、Gleason评分<7、TNM分期I+II、低分化、无淋巴结转移或骨转移的患者,差异有统计学意义(<0.05)。PSA≥10.05μg/mL、fPSA≥1.50μg/mL、CEA≥20ng/mL是前列腺癌预后不良的独立危险因素(<0.05)。

结论

前列腺癌患者血清PSA、fPSA及CEA显著升高,是预后不良的独立危险因素,可作为临床病理评估及预后预测的重要指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbe7/12335835/402110c9d6ba/CMAR-17-1577-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验